Sharekhan

Indegene Ltd

Fri 1/08/2025,15:59:0 | NSE : INDGN

₹ 577.3034.30 (6.32%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 562.95

Previous Close

₹ 543.00

Volume

5474762

Mkt Cap ( Rs. Cr)

₹13855.75

High

₹ 584.70

Low

₹ 557.05

52 Week High

₹ 736.30

52 Week Low

₹ 499.00

Book Value Per Share

₹ 98.34

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Indegene Ltd

Your Vote -

Buy

75.00%

Hold

0.00%

Sell

25.00%

75.00%

4 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

577.30

7558

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

7558

Option Chain

Analyzes market sentiment, predicts Indegene Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Indegene - Announcement under Regulation 30 (LODR)-Investor Presentation

    31 Jul 2025, 6:34PM Analyst Presentation and Fact Sheet on financial results for the quarter ended June 30, 2025
  • Indegene - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    31 Jul 2025, 6:27PM Monitoring Agency Report
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    31 Jul 2025, 6:23PM Press Release regarding financial results for the quarter ended June 30, 2025
  • Indegene - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    31 Jul 2025, 6:09PM Allotment of shares under ESOP Plan 2020.
  • Indegene - Intimation Of Outcome Of Board Meeting

    31 Jul 2025, 6:04PM Intimation of Outcome of Board Meeting
  • Indegene Q1 net profit up 38.34% at Rs 45.10 cr

    31 Jul 2025, 5:51PM The company reported standalone net profit of Rs 45.10 crore for the quarter ended June 30, 2025 as compared to Rs 32.60 crore in the same period last
  • Indegene - Board Meeting Outcome for Intimation Of Outcome Of Board Meeting

    31 Jul 2025, 5:44PM Intimation of Outcome of Board Meeting
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    30 Jul 2025, 8:17PM Indegene Limited has informed the Exchange about Schedule of meet
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    30 Jul 2025, 8:14PM Intimation of Schedule of Investors / Analysts meetings under the SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    30 Jul 2025, 4:28PM Press Release
  • Indegene - Press Release

    30 Jul 2025, 4:19PM Indegene Limited has informed the Exchange regarding a press release dated July 30, 2025, titled ""Everest Group Recognizes Indegene as a Leader in Li
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    24 Jul 2025, 5:28PM Indegene Limited has informed the Exchange about Schedule of meet
  • Indegene - General Updates

    24 Jul 2025, 5:20PM Indegene Limited has informed the Exchange about Intimation of Board Meeting.
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    24 Jul 2025, 5:29PM Intimation of Indegene Q1FY26 Earnings Call
  • Indegene - Board Meeting Intimation for Consideration Of The Unaudited Standalone And Consolidated Financial Results For The

    24 Jul 2025, 5:14PM Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve
  • Indegene - Announcement under Regulation 30 (LODR)-Acquisition

    23 Jul 2025, 3:18PM Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
  • Indegene - Acquisition

    23 Jul 2025, 3:18PM Indegene Limited has informed the Exchange about Acquisition
  • Indegene - Resignation

    22 Jul 2025, 4:45PM Indegene Limited has informed the Exchange regarding Resignation of Mr. Neeraj Bharadwaj as Non- Executive Non- Independent Director of the company w
  • Indegene - Announcement under Regulation 30 (LODR)-Resignation of Director

    22 Jul 2025, 4:43PM Resignation of Non-Executive Non-Independent Director
  • Indegene has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    22 Jul 2025, 7:03AM As of June 2025, 100.00% owned by Public. <p align=justify> Institutional holds 17.24% (Insurance Companies 0.01%) and Non-Institutional holds 82.75%
  • Indegene - Copy of Newspaper Publication

    12 Jul 2025, 2:25PM Indegene Limited has informed the Exchange about Copy of Newspaper Publication
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    11 Jul 2025, 7:08PM Press Release
  • Indegene - Press Release

    11 Jul 2025, 7:07PM Indegene Limited has informed the Exchange regarding a press release dated July 11, 2025, titled ""Indegene Launches NEXT Medical Writing Automation t
  • Indegene - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    11 Jul 2025, 6:41PM Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30, 2025
  • Indegene - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    11 Jul 2025, 6:41PM Indegene Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Indegene - Notice Of Shareholders Meetings-XBRL

    11 Jul 2025, 12:55PM Indegene Limited has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot
  • Indegene - Shareholders meeting

    11 Jul 2025, 12:45PM Indegene Limited has informed the Exchange regarding Notice of Postal Ballot
  • Indegene - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    11 Jul 2025, 12:45PM Postal Ballot Notice
  • Indegene - General Updates

    10 Jul 2025, 12:04PM Indegene Limited has informed the Exchange about General Updates.
  • Indegene - Disclosure Under Regulation 30 Of SEBI LODR Regulations, 2015

    10 Jul 2025, 12:03PM Disclosure under Regulation 30 of SEBI LODR Regulations, 2015
  • Indegene - Press Release

    3 Jul 2025, 10:31AM Indegene Limited has informed the Exchange regarding a press release dated July 03, 2025, titled ""FAST India Collaborates with Indegene to Make India
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    3 Jul 2025, 10:34AM Press Release.
  • Indegene - Press Release

    30 Jun 2025, 4:13PM Indegene Limited has informed the Exchange regarding a press release dated Jun 30, 2025, titled ""Indegene Identified as a Leader in ISG s Provider Le
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    30 Jun 2025, 4:18PM Press release
  • Indegene - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    27 Jun 2025, 9:38PM Voting Results and Scrutinizer's Report of the 27th AGM
  • Indegene - Shareholder Meeting / Postal Ballot-Outcome of AGM

    27 Jun 2025, 9:35PM Voting Results and Scrutinizers Report
  • Indegene - Shareholder Meeting / Postal Ballot-Outcome of AGM

    27 Jun 2025, 9:33PM Voting Results and Scrutinizer's Report
  • Indegene - Shareholders meeting

    27 Jun 2025, 9:32PM Indegene Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 26, 2025
  • Indegene - Trading Window-XBRL

    27 Jun 2025, 1:06PM Indegene Limited has informed the Exchange about Closure of Trading Window
  • Indegene - Trading Window

    27 Jun 2025, 12:53PM Indegene Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Indegene - Disclosure under SEBI Takeover Regulations

    26 Jun 2025, 9:42PM Indegene Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial
  • Indegene - Shareholder Meeting / Postal Ballot-Outcome of AGM

    26 Jun 2025, 7:17PM Proceedings of the 27th Annual General Meeting
  • Indegene - Shareholders meeting

    26 Jun 2025, 7:16PM Indegene Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on Jun 26, 2025
  • Indegene - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    27 Jun 2025, 9:38PM Voting Results and Scrutinizer's Report of the 27th AGM
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    16 Jun 2025, 6:21PM Intimation of Schedule of Investors / Analysts meeting under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    16 Jun 2025, 6:20PM Intimation of Schedule of Investors / Analysts meeting under SEBI (Listing Obligations and Disclosure \r\nRequirements) Regulations, 2015
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Jun 2025, 5:55PM Indegene Limited has informed the Exchange about Schedule of meet
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    3 Jun 2025, 5:53PM Intimation of Schedule of Investors / Analysts meeting under the SEBI (Listing Obligations and Disclosure \r\nRequirements), Regulations, 2015
  • Indegene - Copy of Newspaper Publication

    31 May 2025, 9:35PM Indegene Limited has informed the Exchange about Copy of Newspaper Publication
  • Indegene - Letter To Non-Email Members Providing Web Link Of Annual Report For FY 2024-25.

    30 May 2025, 7:25PM Letter to non-email Members providing web link of Annual Report for FY 2024-25.
  • Indegene - General Updates

    30 May 2025, 7:23PM Indegene Limited has informed the Exchange about letter to non-email Members providing web link of Annual Report for FY 2024-25.
  • Indegene has declared 100% Final dividend for the financial year March 2025

    30 May 2025, 6:04PM Indegene Ltd. on Monday, 28 April 2025, has announced Final dividend of 100 percent on Equity Share, to its shareholders holding shares on the registe
  • Indegene - Business Responsibility and Sustainability Reporting (BRSR)

    30 May 2025, 11:15AM Business Responsibility and Sustainability Reporting (BRSR)
  • Indegene - Updates

    30 May 2025, 11:14AM Indegene Limited has informed the Exchange regarding ''Business Responsibility and Sustainability Report for FY 2024-25'.
  • Indegene - Notice Of Shareholders Meetings-XBRL

    30 May 2025, 10:59AM INDEGENE LIMITED has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 26-May-2025
  • Indegene - Shareholders meeting

    30 May 2025, 10:42AM Annual Report for FY 2024-25 and Notice of the 27th Annual General Meeting ( AGM )
  • Indegene - Annual Report For FY 2024-25 And Notice Of The 27Th Annual General Meeting

    30 May 2025, 10:42AM Annual Report for FY 2024-25 and Notice of the 27th Annual General Meeting
  • Indegene - Copy of Newspaper Publication

    29 May 2025, 1:13PM Indegene Limited has informed the Exchange about Copy of Newspaper Publication
  • Indegene - Alteration Of Capital and Fund Raising-XBRL

    27 May 2025, 8:33PM INDEGENE LIMITED has informed the Exchange regarding Allotment of Securities
  • Indegene - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    27 May 2025, 8:32PM INDEGENE LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
  • Indegene - Appointment

    27 May 2025, 8:20PM Indegene Limited has informed the Exchange regarding re-appointment of Dr. Georgia Nikolakopoulou Papathomas as Non- Executive Independent Director o
  • Indegene - Announcement under Regulation 30 (LODR)-Change in Directorate

    27 May 2025, 8:20PM Re-appointment of Dr. Georgia Nikolakopoulou Papathomas as Independent Director subject to approval of shareholders at the ensuing Annual General Meet
  • Indegene - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    27 May 2025, 8:13PM Allotment under ESOP Scheme 2020
  • Indegene - Allotment of Securities

    27 May 2025, 8:12PM Indegene Limited has informed the Exchange regarding allotment of 1637 securities pursuant to ESOP/ESPS at its meeting held on May 27, 2025
  • Indegene - Record Date For The Purpose Of Dividend

    27 May 2025, 8:08PM Record Date for the purpose of final dividend for the year ended 31 March 2025
  • Indegene - Record Date

    27 May 2025, 8:07PM Indegene Limited has informed the Exchange that Record date for the purpose of Dividend is 13-Jun-2025.
  • Indegene - Intimation Of Outcome Of Board Meeting

    27 May 2025, 8:02PM Outcome of Board Meeting
  • Indegene - Outcome of Board Meeting

    27 May 2025, 7:58PM Indegene Limited has informed the Exchange regarding Board meeting held on May 27, 2025.
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    26 May 2025, 4:12PM Intimation of Schedule of Investors / Analysts meeting under the SEBI (Listing Obligations and Disclosure \r\nRequirements), Regulations, 2015.
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    26 May 2025, 4:12PM Indegene Limited has informed the Exchange about Schedule of meet
  • Indegene - Analysts/Institutional Investor Meet/Con. Call Updates

    22 May 2025, 11:26AM Indegene Limited has informed the Exchange about Schedule of meet
  • Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 May 2025, 11:30AM Intimation of Schedule of Investors / Analysts meeting under the SEBI (Listing Obligations and Disclosure \r\nRequirements), Regulations, 2015.
  • Indegene - Updates

    20 May 2025, 5:32PM Indegene Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulat
  • Indegene - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - \r\nC

    20 May 2025, 5:38PM CIN Update
  • Indegene - Press Release

    19 May 2025, 10:29AM Indegene Limited has informed the Exchange regarding a press release dated May 19, 2025, titled "" Press Release dated May 19, 2025, titled The India
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    19 May 2025, 10:26AM Press Release
  • Indegene - Press Release

    6 May 2025, 5:19PM Indegene Limited has informed the Exchange regarding a press release dated May 06, 2025, titled ""The Indian School of Public Policy And Indegene Anno
  • Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    6 May 2025, 5:19PM Press Release
  • Indegene Ltd

    4 Jun 2025 , 9:49AM Indegene: Carlyle Group is set to exit a 10.2% stake in the company for at least Rs 1,420 crore. The floor price is Rs 580 per share, which is a 6% discount from the current market price.
  • Indegene

    20 Mar 2025 , 11:34AM The company launched a new centre In London to expand in Europe. This aligns with the company's long-term growth strategy in Europe, reiterating its commitment to enable life sciences clients in the region to be future-ready.
  • Indegene

    3 Dec 2024 , 11:16AM Global private equity firm Carlyle-backed CA Dawn Investments likely to divest 2.9% stake in Indegene via block deal at Rs.615 per share. As per media sources, the sale could raise approximately Rs 470 crore, based on the offered floor price.
  • Indegene announces strategic collaboration with Microsoft

    11 Jul 2024 , 11:38AM Indegene collaborates with Microsoft to help life sciences companies scale up Generative AI adoption

Key fundamentals

Evaluate the intrinsic value of Indegene Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1888.2 953.8 795.3 650 442.2
Liabilities 1888.2 953.8 795.3 650 442.2
Equity 47.9 44.4 44.3 0.4 0.3
Gross Profit 180.5 168 177.9 168.7 150.4
Net Profit 181.3 137.9 130.2 132.7 133.4
Cash From Operating Activities 129 176.2 81.9 38.2 54.6
NPM(%) 16.57 13.18 12.94 15.85 26.1
Revenue 1093.6 1045.6 1005.7 836.7 511
Expenses 913.1 877.6 827.8 668 360.6
ROE(%) 7.68 5.84 5.51 5.62 5.65

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
13 Jun 2025 2 100 0 571.5

Peers

Other companies within the same industry or sector that are comparable to Indegene Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Visagar Polytex Ltd 0.79 0.00 0.00 15917.08 -6.09 0.00
India Motor Parts and Accessories Ltd 1035.30 -1.49 15.57 678.66 670.43 2.90
Madhya Pradesh Today Media Ltd 53.45 0.00 9.17 248.41 69.80 0.00
Hathway Cable and Datacom Ltd 15.10 0.80 25.59 96258.04 26.13 0.00

Company Info

Our Company was incorporated as `Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a private limited company, under the Companies Act, 1956, pursuant to a certificate of incorporation dated October 16, 1998, issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli at Ahmedabad. Thereafter, the registered office of our Company was shifted from Gujarat to Karnataka in June 2003, and then, from Karnataka to Maharashtra in May 2014. Further, pursuant to a resolution passed by our Shareholders at the EGM held on February 29, 2016, the name of our Company was changed to `Indegene Private Limited' and a fresh certificate of incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. The name of our Company was changed to better reflect the nature of business undertaken by our Company. Thereafter, the registered office of our Company was shifted from Maharashtra to Karnataka in February 2017. Subsequently, our Company was converted from a private limited company to a public limited company, pursuant to a special resolution passed by our Shareholders at the EGM held on November 7, 2022 and the name of our Company was changed to `Indegene Limited' and a fresh certificate of incorporation was issued to our Company by the RoC, on November 17, 2022.Major events and milestones:2005-Raised funding from Nadathur Holdings & Investments Private Limited-Expanded operations to the USA by incorporating a subsidiary named Indegene, Inc.-Expanded operations to Southeast Asia by incorporating a subsidiary named Indegene Fareast Pte. Ltd. in Singapore2006-Acquisition of Medsn, Inc.1 a company in the USA which is engaged in medical education and marketing business, by one of our Material Subsidiaries, Indegene, Inc.2 through the merger of Medsn Merger Sub, Inc., an erstwhile wholly owned subsidiary of Indegene, Inc. with Medsn, Inc.2007-Expanded our services to include European territory2008-Received BS ISO/IEC 27001:2005 certification for information security management system32009-Received ISO 9001:2000 certification for quality management system42012-Expanded operations to China by incorporating a subsidiary named Indegene Lifesystems Consulting (Shanghai) Co., Ltd.2017-Acquisition of the Encima Group, Inc., a corporation which operates a digital service, marketing automation and analytics services business supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.2020-Acquisition of DT Associates Research and Consulting Services Limited, a consulting services company in UK supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.-Launched Indegene Digital Summit, a symposium on digital transformation and customer experience in life sciences2021-Expanded operations to Japan by incorporating a subsidiary named Indegene Japan, LLC-Raised equity funding from CA Dawn Investments and Brighton Park Capital-Received BS ISO/IEC 27701:2019 certification for privacy information management system52022-Acquisition of Medical Marketing Economics, LLC by one of our Material Subsidiaries, ILSL Holdings, Inc. and subsequent merger of Medical Marketing Economics, LLC with Indegene, Inc.-Expanded global operations with new offices in Mexico2023-Acquisition of Cult Health, a company engaged in the business of providing advertising services to parties in the healthcare sector, by one of our Material Subsidiaries, ILSL Holdings, Inc.-Expanded our presence in Europe with the acquisition of Indegene Healthcare Germany GmbH (formerly Sotus 852 GmbH) by our subsidiary, Indegene Ireland Limited-Launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform2024-Acquisition of Trilogy Writing & Consulting GmbH, a company engaged in providing high-end medical writing to customers that include market-leading pharmaceutical companies, along with three of its wholly owned subsidiaries, by one of our Subsidiaries, Indegene Ireland Limited.-Ranked 167 in The Next 500 India's Largest Emerging Companies by Fortune India

Our Company was incorporated as `Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a private limited company, under the Companies Act, 1956, pursuant to a certificate of incorporation dated October 16, 1998, issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli at Ahmedabad. Thereafter, the registered office of our Company was shifted from Gujarat to Karnataka in June 2003, and then, from Karnataka to Maharashtra in May 2014. Further, pursuant to a resolution passed by our Shareholders at the EGM held on February 29, 2016, the name of our Company was changed to `Indegene Private Limited' and a fresh certificate of incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. The name of our Company was changed to better reflect the nature of business undertaken by our Company. Thereafter, the registered office of our Company was shifted from Maharashtra to Karnataka in February 2017. Subsequently, our Company was converted from a private limited company to a public limited company, pursuant to a special resolution passed by our Shareholders at the EGM held on November 7, 2022 and the name of our Company was changed to `Indegene Limited' and a fresh certificate of incorporation was issued to our Company by the RoC, on November 17, 2022.Major events and milestones:2005-Raised funding from Nadathur Holdings & Investments Private Limited-Expanded operations to the USA by incorporating a subsidiary named Indegene, Inc.-Expanded operations to Southeast Asia by incorporating a subsidiary named Indegene Fareast Pte. Ltd. in Singapore2006-Acquisition of Medsn, Inc.1 a company in the USA which is engaged in medical education and marketing business, by one of our Material Subsidiaries, Indegene, Inc.2 through the merger of Medsn Merger Sub, Inc., an erstwhile wholly owned subsidiary of Indegene, Inc. with Medsn, Inc.2007-Expanded our services to include European territory2008-Received BS ISO/IEC 27001:2005 certification for information security management system32009-Received ISO 9001:2000 certification for quality management system42012-Expanded operations to China by incorporating a subsidiary named Indegene Lifesystems Consulting (Shanghai) Co., Ltd.2017-Acquisition of the Encima Group, Inc., a corporation which operates a digital service, marketing automation and analytics services business supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.2020-Acquisition of DT Associates Research and Consulting Services Limited, a consulting services company in UK supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.-Launched Indegene Digital Summit, a symposium on digital transformation and customer experience in life sciences2021-Expanded operations to Japan by incorporating a subsidiary named Indegene Japan, LLC-Raised equity funding from CA Dawn Investments and Brighton Park Capital-Received BS ISO/IEC 27701:2019 certification for privacy information management system52022-Acquisition of Medical Marketing Economics, LLC by one of our Material Subsidiaries, ILSL Holdings, Inc. and subsequent merger of Medical Marketing Economics, LLC with Indegene, Inc.-Expanded global operations with new offices in Mexico2023-Acquisition of Cult Health, a company engaged in the business of providing advertising services to parties in the healthcare sector, by one of our Material Subsidiaries, ILSL Holdings, Inc.-Expanded our presence in Europe with the acquisition of Indegene Healthcare Germany GmbH (formerly Sotus 852 GmbH) by our subsidiary, Indegene Ireland Limited-Launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform2024-Acquisition of Trilogy Writing & Consulting GmbH, a company engaged in providing high-end medical writing to customers that include market-leading pharmaceutical companies, along with three of its wholly owned subsidiaries, by one of our Subsidiaries, Indegene Ireland Limited.-Ranked 167 in The Next 500 India's Largest Emerging Companies by Fortune India

Read More

Parent Organisation

Indegene Ltd.

Founded

16/10/1998

Managing Director

Mr.Manish Gupta

NSE Symbol

INDGNEQ

FAQ

The current price of Indegene Ltd is ₹ 577.30.

The 52-week high for Indegene Ltd is ₹ 584.70 and the 52-week low is ₹ 557.05.

The market capitalization of Indegene Ltd is currently ₹ 13855.75. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Indegene Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Indegene Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Indegene Ltd shares.

The CEO of Indegene Ltd is Mr.Manish Gupta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT